Treatment of Nasopharyngeal Carcinoma Using Intensity-Modulated Radiotherapy-The National Cancer Centre Singapore Experience

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 5, 2009, Pages 1481-1486

  Tham, Ivan Weng Keong ^a   Hee, Siew Wan ^a   Yeo, Richard Ming Chert ^a   Salleh, Patemah Bte ^a   Lee, James ^a   Tan, Terence Wee Kiat ^a   Fong, Kam Weng ^a   Chua, Eu Tiong ^a   Wee, Joseph Tien Seng ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Intensity modulated; Nasopharyngeal carcinoma; Radiotherapy

Indexed keywords

ACUTE TOXICITY; CIS-PLATIN; COMPLETE RESPONSE; CT SIMULATION; DISEASE FREE SURVIVAL; DOSE LEVELS; HEAD AND NECK; INTENSITY MODULATED; INTENSITY-MODULATED RADIOTHERAPY; LOCAL FAILURE; LOCAL RECURRENCE; NASOPHARYNGEAL CARCINOMA; PARTIAL RESPONSE; PERSISTENT DISEASE; SINGAPORE; TARGET VOLUMES;

CHEMOTHERAPY; PHYSICAL THERAPY; PLATINUM COMPOUNDS; TOXICITY;

RADIOTHERAPY;

CISPLATIN; CONTRAST MEDIUM; FLUOROURACIL; IRIDIUM 192;

ACUTE TOXICITY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLOOD TOXICITY; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DYSPHAGIA; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; ODYNOPHAGIA; OVERALL SURVIVAL; PHARYNX DISEASE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DERMATITIS; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SALIVARY GLAND DISEASE; SINGAPORE; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CANCER CARE FACILITIES; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SINGAPORE; TUMOR BURDEN; YOUNG ADULT;

EID: 71649105983     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.01.018     Document Type: Article

References (21)

1. Lee N., Xia P., Quivey J.M., et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys 53 (2002) 12-22
2. Kam M.K.M., Teo P.M.L., Chau R.M.C., et al. Treatment of nasopharyngeal carcinoma with intensity modulated radiotherapy: The Hong Kong Experience. Int J Radiat Oncol Biol Phys 60 (2004) 1440-1450
3. Wolden S.L., Chen W.C., Pfister D.G., et al. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 64 (2006) 57-62
4. Nowak P.J., Wijers O.B., Lagerwaard F.J., and Levendag P.C. A three-dimensional CT-based target definition for elective irradiation of the neck. Int J Radiat Oncol Biol Phys 45 (1999) 33-39
5. Grégoire V., Levendag P., Ang K.K., et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 69 (2003) 227-236
6. Fong K.W. Brachytherapy. In: Chong V.F.H., and Tsao S.Y. (Eds). Nasopharyngeal carcinoma (1997), Armour, Singapore 103-113
7. Arbuck SG, Ivy SP, Setser A, et al. The Revised Common Toxicity Criteria: Version 2.0. Available at: http://ctep.info.nih.gov. Accessed December 1, 2008.
8. Miller A.B., Hoogstraten B., Staquet M., and Winkler A. Reporting results of cancer treatment. Cancer 47 (1981) 207-214
9. Ng S.H., Chang T.C., Ko S.F., et al. Nasopharyngeal carcinoma: MRI and CT assessment. Neuroradiology 39 (1997) 741-746
10. Chong V.F., Mukherji S.K., Ng S.H., et al. Nasopharyngeal carcinoma: Review of how imaging affects staging. Comput Assist Tomogr 23 (1999) 984-993
11. Chong V.F.H., and Fan Y.F. Skull base erosion in nasopharyngeal carcinoma: Detection by CT and MRI. Clin Radiol 51 (1996) 625-631
12. Lu H., and Yao M. The current status of intensity-modulated radiation therapy in the treatment of nasopharyngeal carcinoma. Cancer Treat Rev 34 (2008) 27-36
13. Yeh S.A., and Huang Y.J. Dose escalation for patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy alone. Am J Clin Oncol 30 (2007) 401-405
14. Lu J.J., Kong L., Shakespeare T.P., et al. Prospective Phase II trial of concomitant boost radiotherapy for Stage II nasopharyngeal carcinoma. Oral Oncol 44 (2008) 703-709
15. Koom W.S., Kim T.H., Shin K.H., et al. Smart (simultaneous modulated accelerated radiotherapy) for locally advanced nasopharyngeal carcinomas. Head Neck 30 (2008) 159-169
16. Wolden S.L., Zelefsky M.J., Kraus D.H., et al. Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. J Clin Oncol 19 (2001) 1105-1110
17. Lee A.W., Tung S.Y., Chan A.T., et al. Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 66 (2006) 142-151
18. Le Q.T. Nasopharyngeal and oropharyngeal carcinomas: Target delineation, therapy delivery and stereotactic boost procedures with intensity-modulated/image-guided radiation therapy. Front Radiat Ther Oncol 40 (2007) 208-231
19. Wee J., Tan E.H., Tai B.C., et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer Stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 23 (2005) 6730-6738
20. Lee A.W., Lau W.H., Tung S.Y., et al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol 23 (2005) 6966-6975
21. Al-Sarraf M., LeBlanc M., Giri P.G., et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099. J Clin Oncol 16 (1998) 1310-1317